التفاصيل البيبلوغرافية
| العنوان: |
Amitriptyline blocks innate immune responses mediated by toll-like receptor 4 and IL-1 receptor: Preclinical and clinical evidence in osteoarthritis and gout. |
| المؤلفون: |
Franco‐Trepat, Eloi, Alonso‐Pérez, Ana, Guillán‐Fresco, María, Jorge‐Mora, Alberto, Crespo‐Golmar, Antia, López‐Fagúndez, Miriam, Pazos‐Pérez, Andrés, Gualillo, Oreste, Belén Bravo, Susana, Gómez Bahamonde, Rodolfo, Franco-Trepat, Eloi, Alonso-Pérez, Ana, Guillán-Fresco, María, Jorge-Mora, Alberto, Crespo-Golmar, Antia, López-Fagúndez, Miriam, Pazos-Pérez, Andrés |
| المصدر: |
British Journal of Pharmacology; Jan2022, Vol. 179 Issue 2, p270-286, 17p, 6 Graphs |
| مصطلحات موضوعية: |
AMITRIPTYLINE, OLDER patients, CARTILAGE cells, IMMUNE response, INTERLEUKIN-1, GOUT, OSTEOARTHRITIS, TOLL-like receptors |
| مستخلص: |
Background and Purpose: Osteoarthritis, a major cause of disability in developed countries does not have effective treatment. Activation of TLR4 and innate immune response factors contribute to osteoarthritis progressive cartilage degradation. There are no clinically available TLR4 inhibitors. Interestingly, the antidepressant amitriptyline could block this receptor. Thus, we evaluated amitriptyline anti-TLR4 effects on human osteoarthritis chondrocytes in order to repurpose it as an inhibitor of innate immune response in joint inflammatory pathologies.Experimental Approach: Using in silico docking analysis, RT-PCR, siRNA, elisa, proteomics and clinical data mining of drug consumption, we explored the clinical relevance of amitriptyline blockade of TLR4-mediated innate immune responses in human osteoarthritis chondrocytes.Key Results: Amitriptyline bound TLR4 but not IL-1 receptor. Interestingly, amitriptyline binding to TLR4 inhibited TLR4- and IL-1 receptor-mediated innate immune responses in human osteoarthritis chondrocytes, synoviocytes and osteoblasts cells. Amitriptyline reduced basal innate immune responses and promoted anabolic effects in human osteoarthritis chondrocytes. Supporting its anti-innate immune response effects, amitriptyline down-regulated basal and induced expression of NLRP3, an inflammasome member from IL-1 receptor signalling linked to osteoarthritis and gout pathologies. Accordingly, mining of dissociated and aggregated drug consumption data from 107,172 elderly patients (>65 years) revealed that amitriptyline consumption was significantly associated with lower colchicine consumption associated with inflammatory gout flare treatment.Conclusion and Implications: Amitriptyline blocks TLR4-, IL-1 receptor and NLRP3-dependent innate immune responses. This together with clinical data amitriptyline could be repurposed for systemic or local innate immune response management in diverse joint inflammatory pathologies. [ABSTRACT FROM AUTHOR] |
|
Copyright of British Journal of Pharmacology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder